Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction

Citation
A. Sampalo et al., Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction, BLOOD, 96(9), 2000, pp. 3168-3174
Citations number
33
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
96
Issue
9
Year of publication
2000
Pages
3168 - 3174
Database
ISI
SICI code
0006-4971(20001101)96:9<3168:CLLBCI>2.0.ZU;2-G
Abstract
A variable degree of humoral immunodeficiency is a common feature in patien ts with B-cell chronic lymphocytic leukemia (B-CLL), The aim of this study was to explore the possibility that B-CLL cells play a direct role in this phenomenon. To this end, patients' bone marrow (BM) immunoglobulin (Ig)-sec reting cells were cocultured with autologous purified B-CLL cells. The resu lts show that tumoral cells inhibited the spontaneous IgG secretion by BM p lasma cells, and this effect increased after PMA-induction of B-CLL cells. This inhibitory process was proportional to the number of B-CLL cells added and depended on cellular contact. Adhesion molecules did not appear to be involved in the cellular interaction, because the inclusion of blocking ant ibody to a variety of these proteins did not reverse the inhibitory phenome non. However, the addition of monoclonal antibody that blocked the function of either CD95 or CD95L clearly reversed B-CLL cell inhibition on autologo us BM plasma cells. These latter cells were shown to express CD95, and B-CL L cells contained detectable quantities of CD95L at the level of messenger RNA and protein. Annexin V-binding experiments revealed increased apoptosis of BM Ig-secreting cells when cocultured with autologous B-CLL cells. Fina lly, this inhibitory phenomenon might be operative in vivo because (a) ther e was a good correlation between the intensity of the inhibitory effect in vitro and the serum IgG level exhibited by every patient and (b) B-CLL cell s also inhibited in vivo antigen-induced IgG-tetanus toroid-secreting cells obtained from normal Immunized subjects. Collectively, these data suggest that B-CLL cells inhibit autologous CD95-bearing Ig-secreting cells by the interaction with CD95L present on B-CLL cells and, hence, contribute to the state of humoral immunodeficiency that occurs in these patients. (C) 2000 by The American Society of Hematology.